BrachytherapyHumansMaleBrachytherapyProstatic NeoplasmsMiddle Aged
MRI-based predictors of treatment failure in intermediate-risk prostate cancer treated with high-dose-rate brachytherapy as monotherapy.
Jacob F Oyeniyi, Joseph S Lee, Chen Shen, Bailey A Loving, Sirisha R Nandalur, Andrew B Thompson, Kiran R Nandalur, Zachary A Seymour, Evelyn L Sebastian, Amy Limbacher, Alvaro Martinez, Daniel J Krauss
Published: 202610.1016/j.brachy.2025.10.012
Abstract
OBJECTIVE: To identify MRI features associated with treatment failure in intermediate-risk prostate cancer patients treated with HDR brachytherapy monotherapy. METHODS: We analyzed 115 men with intermediate-risk prostate cancer who underwent definiti…
Preview only. Read the full abstract at the source